Magazine
Latest Issue

Bipolar disorder comes to Britain

By Tom Nuttall  

The latest trend in American psychiatry—re-diagnosing the clinically depressed as victims of bipolar disorder—is on its way to Britain. Patients previously prescribed drugs like Prozac or Seroxat are trading in their antidepressants for mood stabilisers that level out the emotional peaks and troughs that characterise bipolar. Is this a sign of genuine psychiatric progress, or merely the latest diagnostic fad? Annie Maccoby Berglof, who experienced this “diagnostic shift” herself back in the 1970s in the US, explains in the new issue of Prospect.

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to letters@prospect-magazine.co.uk

More From Prospect